Morgan Stanley cuts T. Rowe Price stock price target on AUM decline

The setup is more about the trajectory of franchise economics than the headline AUM print. A mature active manager with persistent outflows can still defend earnings near-term by cutting variable spend, but that only postpones the market’s re-rating problem: if organic decay stays in the low-single-digits, every rally in the equity market can paradoxically worsen the relative burden of passive competition and make fee compression look more structural. The slight upward tweak to near-term EPS is therefore less important than the downward drift in outer-year expectations, which signals analysts are assuming no meaningful operating leverage from market beta alone.

The dividend increase is a useful capital-allocation signal, but it also narrows strategic flexibility at a time when the business likely needs more optionality around alternatives, distribution, and product development. That matters because the path to stabilizing flows is probably not a generic “risk assets up” trade; it requires either genuine product differentiation or a step-up in retirement/wealth channel penetration. Leadership changes in alternatives are directionally supportive, but the second-order effect is that the market will now judge management on whether alternatives can offset core active-equity leakage rather than simply complement it.

The contrarian read is that the stock may not be as cheap as it looks on trailing multiples if the denominator keeps shrinking. A flat multiple on falling forward earnings is not value if the market eventually assigns a lower terminal multiple to a business with low growth and weak flow momentum. The near-term catalyst set is limited unless equity markets remain buoyant long enough for AUM to mask the redemptions; if risk assets wobble, this becomes a faster de-rating story than consensus expects.